冠心病慢性心力衰竭患者室性心律失常的临床治疗研究

Clinical Treatment of Ventricular Arrhythmia in Patients With Chronic Heart Failure of Coronary Heart Disease

目的分析在冠心病慢性心力衰竭患者室性心律失常治疗过程中加施胺碘酮的临床效果。方法将2015年9月—2017年9月我院接诊的72例冠心病慢性心力衰竭患者纳入本次研究,依照随机数字表法,将其分成基础治疗组(n=36)和胺碘酮组(n=36);基础治疗组患者接受常规基础治疗,胺碘酮组接受常规基础治疗+胺碘酮给药治疗。结果胺碘酮组患者的治疗总有效率、左室射血分数、室性早搏总数均优于基础治疗组,差异具有统计学意义(P<0.05)。结论与实施常规基础治疗相比,在患者室性心律失常临床治疗中加施胺碘酮的疗效更为显著,促使患者室性心律失常得以更为有效的改善。

Objective To analyze the clinical effect of amiodarone in the treatment of ventricular arrhythmia in patients with chronic heart failure of coronary heart disease. Methods 72 cases of patients with CHD who were admitted to our hospital from September 2015 to September 2017 were enrolled in this study. According to the random number table, they were divided into basic treatment group（n =36） and amiodarone group（n =36）. Patients in the primary treatment group with chronic heart failure of coronary heart disease only received routine basic treatment. Amiodarone group patients with chronic heart failure of coronary heart disease received routine basic treatment and amiodarone administration. Results The total effective rate, the left ventricular ejection fraction and the ventricular premature beat in the amiodarone group were better than those in the basic treatment group, the difference was statistically significant（P 〈 0.05）. Conclusion Compared with routine basic therapy, amiodarone is more effective in the treatment of ventricular arrhythmia in patients with coronary heart disease and chronic heart failure, so that ventricular arrhythmia can be improved more effectively.